Fig. 3From: The therapeutic effect of larval saliva and hemolymph of Lucilia sericata on the treatment of Leishmania major lesion in BALB/c mice946Dose-response curves regarding the effect of Lucilia sericata larval-derived products on Leishmania major promastigotes (IC50) using MTT assay. a Larval saliva IC50 vs. larval hemolymph IC50 at 24Â h. b Larval saliva IC50 vs. larval hemolymph IC50 at 48Â h. c Larval saliva IC50 vs. larval hemolymph IC50 at 72Â h. d Larval saliva IC50 vs. larval hemolymph IC50 at 96Â h and compared with standard treatment (glucantime)Back to article page